Clinical Trials Logo

Aging clinical trials

View clinical trials related to Aging.

Filter by:

NCT ID: NCT04645576 Completed - Aging Clinical Trials

Evaluation of the Efficacy and Safety of an Injectable Hyaluronic Acid-based Filler, Art Filler® Volume: Comparative Single-blind Study of the Non-inferiority Versus Juvéderm® Voluma on the Midface, Temple and Jaw-line and Non-comparative Study on the Chin. (AF3)

AF3
Start date: May 14, 2019
Phase: N/A
Study type: Interventional

The function of injectable fillers for the treatment of dermal contour deformities is to smooth dermal depressions formed by the loss of volume. These fillers (also known as soft tissue augmentation devices) can restore the age-related volume loss of the face, balance the disproportions or correct topographical anomalies. A previous study has already shown the efficacy of Art Filler Volume on the midface, but this study was not comparative. It was thus interesting to compare the efficacy of Art Filler Volume to a reference product but also to test its efficacy on other areas including the temple, jaw-line and chin.

NCT ID: NCT04645134 Completed - Aging Clinical Trials

Physical Activity and Cognitive Function in Older Adults: A Novel Role for GPLD1

BrainFit
Start date: April 1, 2021
Phase:
Study type: Observational

The investigators are conducting a cross-sectional, observational study to investigate whether plasma GPLD1 concentrations are associated with higher cognitive function and better brain structure and function in two groups of older adults with high or low levels of physical activity.

NCT ID: NCT04638322 Completed - Quality of Life Clinical Trials

Effects of Functional Training by High Intensity Intervals in Older Adults With Mild Cognitive Impairment.

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

To analyze the effects of a high intensity interval functional training program (HIFT), in the cognitive and functional capacities of Colombian older adults with mild cognitive impairment.

NCT ID: NCT04635462 Completed - Aging Clinical Trials

The Cognitive and spOrt Virtual EPIC Training Study

COVEPIC
Start date: May 18, 2020
Phase: N/A
Study type: Interventional

The proposed COVEPIC trial is designed to document the effects of remote monitoring of physical exercise and home-based cognitive training on cognitive and physical functions in older adults.

NCT ID: NCT04635124 Completed - Aging Clinical Trials

Optimal Dog Visits

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

The aim of this project is to study how an the intensity of dog contact during dog visits in nursing homes can affect the immediate response to, and the general effect of the visits, and whether the residents' level of cognitive impairment affects the response and benefit of dog visits. The participants are randomly assigned to receive one type of visits (12 visits in total) out of three possible visit types (1: visit with a dog; 2: visit with a dog, including a planned activity, 3 visit without a dog, including a planned activity). The residents received 2 visits per week for 6 weeks. The behaviour of the participants during visits is recorded. Before and after the intervention period, participants are scores on psychometric scales for cognitive impairment level, daily function level and symptoms of depression.

NCT ID: NCT04633499 Completed - Aging Clinical Trials

Effects of tDCS on Social Cognition in Aging

SoCoStim
Start date: August 1, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to explore the effect of transcranial direct current stimulation (tDCS) on either the right tempo-parietal junction (rTPJ) or the dorsomedial prefrontal cortex (dmPFC) in healthy older adults (replication in a different sample of a study by Martin et al., 2020).

NCT ID: NCT04630418 Completed - Aging Clinical Trials

NanoSilk Cosmo: Evaluation of a Novel Silk Complex on Biophysical Parameters Related to Skin Aging

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

Silk is a naturally occurring protein polymer that is approved for medical use by the U.S Food and Drug Administration (FDA). Silk fibroin fiber biomaterial has shown promising results for tissue regeneration demonstrated through in vivo and in vitro animal models. The investigators of this study have previously shown that patients' report improvement in common skin aging findings including wrinkles, sagginess, and dry skin. The investigators will continue this assessment of patients' skin perception as well as add on objective measures of skin resilience, elasticity, and hydration. The investigators will provide participants with a demographic survey, and the FACE-Q survey, a validated survey, prior to administration of NanoSilk Cosmo, to assess perception of aging, satisfaction with facial appearance, satisfaction with skin. The participant will undergo baseline evaluation of several objective measures of skin hydration, elasticity and overall healthy using non-invasive devices (Courage+Khazaka Corneometer Probe, Courage+Khazaka Electronic GmbH Cutometer Dual MPA 580, and VISIA-CA GEN 7). The participants will be provided with 30ml of the NanoSilk Cosmo and with extensive instruction on administration of the product. Participants will return to clinic after 4 weeks of using the product to perform the FACE-Q and re-evaluation of several objective measures of the skin using non-invasive devices (Courage+Khazaka Corneometer Probe, Courage+Khazaka Electronic GmbH Cutometer Dual MPA 580, and VISIA-CA GEN 7).

NCT ID: NCT04627493 Completed - Aging Clinical Trials

Improving Physical Activity and Mobility Via Live Online Exercise Sessions for Older Adults

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

The COVID-19 pandemic has undoubtedly resulted in an increased level of personal anxiety, reduced access to support services, and as a secondary complication, increased physical inactivity. Older people appear to be at higher risk of several secondary complications and long-term negative health outcomes. These complications include declines in physical health and mobility, social isolation, and worsening mental health. There is strong evidence in older persons that supports the role of exercise and physical activity in: the alleviation of strength and mobility declines, reducing anxiety and depression, and alleviating cognitive declines. Exercise-based intervention trials have also been shown to reduce social isolation and loneliness. This study will compare an online exercise program delivered via Zoom and a waitlist control group in healthy older persons.

NCT ID: NCT04615897 Completed - Aging Clinical Trials

Efficiency of New Technologies in the Aging Process

Start date: March 2013
Phase: N/A
Study type: Interventional

This study tries to analyze the effectiveness of the application of the new technology in the maintenance of an active time. To do this, the investigators performed a laboratory test where they evaluated the physical and cognitive variables before and after the intervention and analyzed the improvement in the psychocognitive abilities in the experimental group and the use of physical and cognitive functions in the control group.

NCT ID: NCT04615169 Completed - Aging Clinical Trials

Multi-component Cognitive Intervention for Older Adults With Mixed Cognitive Abilities

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

Objective: To assess the feasibility and preliminary effectiveness of an evidence-driven, pragmatic multi-component cognitive intervention with simulated everyday tasks (MCI-SET) with an inclusive group design in community centers Methods: One group, pre-test, post-test, and 3-month follow up research design. The participants who were >=65 and frail, dependence in >= one activity of daily living, or with a confirmed dementia from eight community centers. MCI-SET consisted 12 two-hour weekly group sessions. Feasibility was described with intervention development, fidelity, and acceptability. Outcomes included general daily functioning, general cognition, memory, attention, executive functioning, and processing speed.